| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/27/2007 | US7195760 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies |
| 03/27/2007 | US7195759 Therapeutic uses of glandular kallikrein |
| 03/27/2007 | US7195757 Enterobacteriaceae bacteria comprises a polynucleotide that encodes an antigen of a pathogen that is different than the pathogenic Enterobacteriaceae bacteria |
| 03/27/2007 | US7195750 Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2242750C Antibodies with reduced net positive charge |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/27/2007 | CA2133441C Haemophilus somnus immunogenic proteins |
| 03/22/2007 | WO2007033329A1 Synthetic polyvalent carbohydrates as components of microbicides |
| 03/22/2007 | WO2007033291A2 Regulatory cd8+t cells induced with anti-cd3 antibody |
| 03/22/2007 | WO2007033216A2 Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state |
| 03/22/2007 | WO2007033167A2 Compositions and methods for detecting and treating cancer |
| 03/22/2007 | WO2007033140A2 Prok2 antagonists and methods of use |
| 03/22/2007 | WO2007033063A2 Regulation of the hedgehog signaling pathway and uses thereof |
| 03/22/2007 | WO2007032804A2 Novel uses for anti-ige therapy |
| 03/22/2007 | WO2007032376A1 SECRETORY IgA AND IgG ANTIBODIES-INDUCING AGENT |
| 03/22/2007 | WO2007031996A1 Compositions and methods for diagnosing and treating an inflammation |
| 03/22/2007 | WO2007031867A2 A hepatitis c virus non-stru tural ns3/4a fusion gene |
| 03/22/2007 | WO2007031574A2 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | WO2007031572A1 Fish vaccine |
| 03/22/2007 | WO2007031550A2 Method for preparing immunoglobulin libraries |
| 03/22/2007 | WO2007031334A2 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 03/22/2007 | WO2007031322A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 03/22/2007 | WO2007031319A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 03/22/2007 | WO2007031034A1 Dengue virus capsid protein which induces a protective response and pharmaceutical composition |
| 03/22/2007 | WO2007031030A1 Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor |
| 03/22/2007 | WO2007030992A1 Medicament for the treatment of tumors and its use for manufacturing a medicament for the treatment of tumors |
| 03/22/2007 | WO2007030930A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | WO2007030901A1 Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| 03/22/2007 | WO2007016598A3 Influenza vaccine compositions and methods of use thereof |
| 03/22/2007 | WO2007014455A9 Cancerous disease modifying antibodies |
| 03/22/2007 | WO2007008780A3 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 03/22/2007 | WO2007002149A3 Methods and compositions relating to a vaccine against prostate cancer |
| 03/22/2007 | WO2007001851A3 Compositions and methods for the diagnosis and treatment of tumor |
| 03/22/2007 | WO2006138737A3 Methods of purifying anti a beta antibodies |
| 03/22/2007 | WO2006130472A3 Identification of rac1b as a marker and mediator of matrix metalloproteinase-induced malignancy |
| 03/22/2007 | WO2006125668A3 Anti-cd16 binding molecules |
| 03/22/2007 | WO2006125143A3 Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| 03/22/2007 | WO2006121773A3 Compositions and assays to detect influenza virus a and b nucleic acids |
| 03/22/2007 | WO2006116592A9 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 03/22/2007 | WO2006114704A3 P-cadherin antibodies |
| 03/22/2007 | WO2006110915A3 Vaccine formulations for leishmania |
| 03/22/2007 | WO2006104989A3 Altered antibody fc regions and uses thereof |
| 03/22/2007 | WO2006099141A3 Anti-mesothelin antibodies |
| 03/22/2007 | WO2006096800A3 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 03/22/2007 | WO2006066214A3 Use of flagellin in the immunotherapy of yersinia pestis |
| 03/22/2007 | WO2006048753A3 Anti-bacterial vaccine compositions |
| 03/22/2007 | WO2006039631A3 Methods and compositions for treating renal cell carcinoma related pathologies |
| 03/22/2007 | WO2006020581A3 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 03/22/2007 | WO2005120550A3 A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor |
| 03/22/2007 | WO2005092377A9 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 03/22/2007 | WO2004009837A3 A high resolution typing system for pathogenic mycobacterium tuberculosum |
| 03/22/2007 | WO2002011563A8 Food supplement |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066810 Homogeneous preparations of il-28 and il-29 |
| 03/22/2007 | US20070066809 Monoclonal antibodies to gastrin hormone |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066558 Molecular determinants of myeloma bone disease and use thereof |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066534 Comprising a polypeptide conjugated to one or more lipid moieties; synthetic; highly soluble; contraceptive agent ; vaccine |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070065925 Vaccine containing cell transformed with a nucleotide sequence of the genome of Porcine circovirus type B |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065852 HIV recombinant vaccine |
| 03/22/2007 | US20070065810 Diagnosis and treatment of cervical cancer |
| 03/22/2007 | US20070065499 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/22/2007 | US20070065498 Encapsulated arsenic drugs |
| 03/22/2007 | US20070065482 Articles including natural biodegradable polysaccharides and uses thereof |
| 03/22/2007 | US20070065468 Chimeric allergens for immunotherapy |
| 03/22/2007 | US20070065467 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 03/22/2007 | US20070065466 Clostridium difficile vaccine |
| 03/22/2007 | US20070065465 Conjugate vaccines for the prevention of dental caries |
| 03/22/2007 | US20070065464 n immunogenic composition comprising a combination of Streptococcus pyogenes (GAS) antigens in pure form consisting of two to ten GAS antigens including a Spy0269 antigen comprising the amino acid sequence SEQ ID NO:1 and a Spy0416 antigen comprising the amino acid sequence SEQ ID; NO:122.; vaccines |
| 03/22/2007 | US20070065463 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions |
| 03/22/2007 | US20070065462 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 03/22/2007 | US20070065461 Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni |
| 03/22/2007 | US20070065460 differentail precipitation, concentration, difiltration of polysacchride using cationic detergent hexadecyltrimethyl ammonium bromide, ethanol, a anionic detergent sodium deoxycholate; straightforward, reproducible and cost-effective; polysaccharide is obtained from Haemophilus influenza type b |
| 03/22/2007 | US20070065459 Recombinant modified Ankara (MVA) vector in combination with a pharmaceutically acceptable carrier; into which is inserted within excisions II and/or III DNA sequences coding for early E6 or E7 polypeptide of a papillomavirus; late L1 and L2 polypeptides and immunostimulatory polypeptides |
| 03/22/2007 | US20070065458 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/22/2007 | US20070065457 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/22/2007 | US20070065455 relates to osteopontin (Eta-1) polypeptides ; for enhancing an immune response in an animal; for therapy and prophylaxis of infectious diseases or cancer; immunization |
| 03/22/2007 | US20070065454 Liposomal vaccine |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065452 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065450 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 03/22/2007 | US20070065449 Method of treating cancer, especially soft tissue sarcoma utilizing gemcitabine in combination with docetaxel and anti-VEGF therapy (bevacizumab) |
| 03/22/2007 | US20070065448 Methods and compositions for treating diseases targeting MABA1 |
| 03/22/2007 | US20070065447 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| 03/22/2007 | US20070065446 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065444 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 03/22/2007 | US20070065443 Fructoseamine 3 kinase and the formation of collagen and elastin |